3rd Oct 2017 7:00 am |
RNS |
Completion of Acquisition of PSR Group BV |
28th Sep 2017 10:46 am |
RNS |
Result of Placing |
28th Sep 2017 7:02 am |
RNS |
Acquisition of PSR Group BV and Placing |
27th Sep 2017 7:00 am |
RNS |
Commercialisation Deal on Haemostatix Products |
18th Sep 2017 7:00 am |
RNS |
Interim Results |
21st Aug 2017 7:06 am |
RNS |
CEL-SCI Corporation issues restricted shares |
14th Aug 2017 12:31 pm |
RNS |
FDA removal of hold on Ph3 trial with Multikine |
14th Aug 2017 7:00 am |
RNS |
Notice of Results |
24th Jul 2017 7:00 am |
RNS |
Recruitment complete early for Phase IIb study |
4th Jul 2017 12:30 pm |
RNS |
Investor Meeting |
21st Jun 2017 7:00 am |
RNS |
PeproStat study passes recruitment mid-point |
16th Jun 2017 5:44 pm |
RNS |
Result of AGM |
16th Jun 2017 7:00 am |
RNS |
Appointment of CEO |
22nd May 2017 7:00 am |
RNS |
Appointment of N+1 Singer as joint broker |
12th May 2017 4:54 pm |
RNS |
Annual Report and Notice of AGM |
8th May 2017 12:00 pm |
RNS |
Issue of Shares to Former PharmInvent Shareholders |
2nd May 2017 7:00 am |
RNS |
Co-Development Partner News |
13th Apr 2017 7:00 am |
RNS |
Board and Management Changes |
4th Apr 2017 10:50 am |
RNS |
Director/PDMR Shareholding |
3rd Apr 2017 7:00 am |
RNS |
Partner Asarina Pharma announces successful data |
28th Mar 2017 7:00 am |
RNS |
Unaudited Preliminary Results for 2016 |
21st Mar 2017 7:00 am |
RNS |
Notice of Preliminary Results |
20th Mar 2017 7:00 am |
RNS |
Initiates Phase II Study of Topical PeproStat |
20th Feb 2017 7:00 am |
RNS |
Modus Therapeutics Raises SEK 32 Million |
6th Feb 2017 7:02 am |
RNS |
Positive Phase II top-line results of Lorediplon |
31st Jan 2017 4:00 pm |
RNS |
Completion of ZoptrexT Phase 3 Clinical Trial |
17th Jan 2017 7:00 am |
RNS |
Trading Statement |
30th Nov 2016 4:35 pm |
RNS |
Award of Options by CEO to CFO and General Counsel |
29th Nov 2016 7:00 am |
RNS |
Acquisition of PharmInvent |
21st Nov 2016 7:00 am |
RNS |
Proposed Board Changes |
16th Nov 2016 7:00 am |
RNS |
Research Update from Modus Therapeutics |
15th Nov 2016 4:33 pm |
RNS |
Holding(s) in Company |
1st Nov 2016 7:00 am |
RNS |
Co-Development Agreement with Asarina AB |
24th Oct 2016 7:00 am |
RNS |
Ergomed notes news from co-development partner |
14th Oct 2016 7:00 am |
RNS |
Fourth licensing agreement for Zoptrex |
26th Sep 2016 7:00 am |
RNS |
Half-year Report |
22nd Sep 2016 7:00 am |
RNS |
Contract win validates rationale of acquisitions |
16th Sep 2016 10:56 am |
RNS |
Ergomed receives a "buy" recommendation |
8th Sep 2016 7:00 am |
RNS |
Recruitment completed in phase IIa clinical trial |
7th Sep 2016 11:30 am |
RNS |
Notice of Results |